CBS-TV News Feature Reports on the Promising Results of a Recent Cognizin Study

(New York, NY) April 14, 2008 – A report by WBZ-TV, the CBS-TV affiliate in Boston, focusing on the most recent Cognizin Citicoline study, is being fed to all CBS-TV news affiliates nationwide. The news feature includes an interview with Dr. Perry Renshaw, director at McLean Hospital and professor at Harvard Medical School on the Cognizin study which demonstrated the patented supplement’s positive impact on the cognitive skills of healthy, middle aged adults. To view the CBS-TV report and accompanying article, visit

Kyowa Hakko is an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. The maker of the branded ingredients Cognizin® Citicoline, Resilen™ Hyaluronic Acid , Lumistor® L-Hydroxyproline, Kyowa CoQ10®, Setria® Glutathione and Sustamine™ Alanyl Glutamine, Kyowa offers manufacturers and formulators one of the industry’s most extensive lines of over 50 amino acids and related compounds, including D-Amino acids and branch-chain amino acids, as well as nucleic acids, bio-products and fine chemicals.

# # # #

Dr. Perry Renshaw
Dr. Perry Renshaw, M.D., Ph.D. is director of the Brain Imaging Center at McLean Hospital and professor of Psychiatry at Harvard Medical School. He is the leading scientific researcher on the health benefits of Citicoline. Dr. Renshaw attended the University of Pennsylvania School of Medicine where he received his Ph.D. in biophysics and his M.D.
Media Note: For further information, or to schedule an interview, please contact Karen Todd at 734.214.2296 or [email protected]. For more information about Kyowa Hakko visit

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.